Stocks in news: M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma

[hfe_template id='11223'] [ad_1]
The new expiry series began on a weak note, with markets slipping nearly two percent, weighed down by weak global cues. In today's trade, shares of M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma among others will be in focus due to various news developments.

M&M
Mahindra & Mahindra is working to scale up some of its smaller businesses to match its portfolio of multiple large companies, the top executive at the tractor-to-technology group told ET.


Glenmark Pharma
Glenmark Pharma is recalling close to 1.5 million bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the US health regulator.

Maruti, Hyundai, Tata Motors
Maruti Suzuki reported marginal growth while Hyundai and Tata Motors posted a decline in their sales in February as a slowdown in the market continued with demand remaining muted.


Indian Overseas Bank
Growfast
  • Maximise Returns by Investing in the Right Companies

    Stock Trading

    Maximise Returns by Investing in the Right Companies

    By - The Economic Times, Get Certified By India's Top Business News Brand

  • Renko Chart Patterns Made Easy

    Stock Trading

    Renko Chart Patterns Made Easy

    By - Kaushik Akiwatkar, Derivative Trader and Investor

  • Candlesticks Made Easy: Candlestick Pattern Course

    Stock Trading

    Candlesticks Made Easy: Candlestick Pattern Course

    By - elearnmarkets, Financial Education by StockEdge

  • Dow Theory Made Easy

    Stock Trading

    Dow Theory Made Easy

    By - Vishal Mehta, Independent Systematic Trader

  • Market 101: An Insight into Trendlines and Momentum

    Stock Trading

    Market 101: An Insight into Trendlines and Momentum

    By - Rohit Srivastava, Founder- Indiacharts.com

  • Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading

    Stock Trading

    Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading

    By - Rohit Srivastava, Founder- Indiacharts.com

  • Market 103: Mastering Trends with RMI and Techno-Funda Insights

    Stock Trading

    Market 103: Mastering Trends with RMI and Techno-Funda Insights

    By - Rohit Srivastava, Founder- Indiacharts.com

  • Market 104: Options Trading: Kickstart Your F&O Adventure

    Stock Trading

    Market 104: Options Trading: Kickstart Your F&O Adventure

    By - Saketh R, Founder- QuickAlpha, Full Time Options Trader

  • ROC Made Easy: Master Course for ROC Stock Indicator

    Stock Trading

    ROC Made Easy: Master Course for ROC Stock Indicator

    By - Souradeep Dey, Equity and Commodity Trader, Trainer

  • RSI Made Easy: RSI Trading Course

    Stock Trading

    RSI Made Easy: RSI Trading Course

    By - Souradeep Dey, Equity and Commodity Trader, Trainer

  • Technical Analysis for Everyone - Technical Analysis Course

    Stock Trading

    Technical Analysis for Everyone - Technical Analysis Course

    By - Abhijit Paul, Technical Research Head, Fund Manager- ICICI Securities

  • Introduction to Technical Analysis & Candlestick Theory

    Stock Trading

    Introduction to Technical Analysis & Candlestick Theory

    By - Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert

Indian Overseas Bank (IOB) received a Rs 699.52 crore demand notice from the Deputy Commissioner (ST)-III, Large Taxpayers Unit, Chennai-35, for alleged GST liabilities related to the assessment year 2020-21.

Ujjivan SFB
Ujjivan Small Finance Bank completed sale of stressed loan portfolio with outstanding of Rs 364.51 crore to an Asset Reconstruction Company (ARC) for Rs 34.26 crore

Sun Pharma
India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes drug in the next four to five years.
[ad_2] Source link https://mrgaga.in/stocks-in-news-mm-glenmark-pharma-tata-motors-iob-sun-pharma/?feed_id=47082&_unique_id=67c506cd64b98

Comments

Post a Comment

Popular posts from this blog

India VIX jumps 100% in one month. Could fear levels take Nifty further down?

Image
[hfe_template id='11223'] [ad_1] Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
Read more

Can Sensex, Nifty snap 2-day fall on Monday? 7 factors that could decide market mood this week

Image
[hfe_template id='11223'] [ad_1] Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
Read more

Waaree Energies shares in focus after Q4 profit rises 34% to Rs 619 crore, revenue up 36%

Image
[hfe_template id='11223'] [ad_1] Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
Read more